Abstract:ObjectiveTo investigate texture parameters of contrast-enhanced computed tomography (CT) images before and after transarterial chemoembolization (TACE) as a tool for assessing the therapeutic response and survival predication in hepatocellular carcinoma (HCC).Materials and methodsData of 77 HCC patients who underwent three-phase dynamic contrast-enhanced CT examination within 4 weeks before and 4–8 weeks after TACE were collected and efficacy evaluation was performed according to the modified Response Evaluation Criteria in Solid Tumors (mRECIST) standard. The remission group consisted of 31 patients (12 with complete remission+19 with partial remission), while the non-remission group consisted of 46 patients (27 with stable disease+19 with progressive disease). Full-volume manual delineation of the region of interest (ROI) and texture analysis of the ROI were performed on the CT images using FireVoxel software. Changes in the 48 texture parameters from three-phase CT images before and after TACE were calculated and compared between the two groups. The receiver operating characteristic (ROC) curve and the areas under the curve (AUC) were used to analyze the diagnostic performance of texture parameters. A multifactorial Cox model was used for predicting survival. The C-indices of texture parameter difference values with predictive value, texture features model, and texture features combined with mRECIST in predicting OS were compared with those of mRECIST.ResultsA total of 41 changes in texture parameters were statistically significant between the remission and non-remission groups. The receiver operating characteristic (ROC) curve showed that the AUC of changes in the 90th percentile in the arterial phase was the largest at 0.842. When the cut-off value was 70.50, the Youden index was the largest (0.621), and the sensitivity and specificity were 0.710 and 0.911, respectively. Three changes in texture parameters were independent factors associated with patient survival, with a hazard of 0.173, 2.068, and 1.940, respectively. The C-index of the OS predicted by the texture features model was not statistically different from that of the mRECIST (0.695 vs. 0.668, p=0.493). While the C-indices of skewness in the portal venous phase combined with mRECIST (0.729, p=0.015), skewness in the delayed phase combined with mRECIST (0.715, p=0.044), and skewness in both two phases combined with mRECIST (0.728, p=0.017) were statistically different.ConclusionChanges in the texture parameters of CT images before and after TACE treatment can be used to obtain relevant grayscale histogram parameters for evaluating the early efficacy of TACE in HCC treatment. And the texture analysis combined with mRECIST may be superior to the mRECIST alone in predicting survival in HCC after TACE treatment.

MR Texture Analysis: Potential Imaging Biomarker for Predicting the Chemotherapeutic Response of Patients with Colorectal Liver Metastases

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.

SU‐E‐J‐256: Predicting Metastasis‐Free Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemo‐Radiotherapy by Data‐Mining of CT Texture Features of Primary Lesions

Whole Tumor Based Texture Analysis of Magnetic Resonance Diffusion Imaging for Colorectal Liver Metastases: A Prospective Study for Diffusion Model Comparison and Early Response Biomarker.

Potential of MR Histogram Analyses for Prediction of Response to Chemotherapy in Patients with Colorectal Hepatic Metastases

475P Diffusion Kurtosis Imaging Signature in Predicting the Chemotherapeutic Response of Colorectal Liver Metastases: the Result of the FDZL-MRinCLM Study

Ct Texture Analysis in Colorectal Liver Metastases: A Better Way Than Size and Volume Measurements to Assess Response to Chemotherapy?

A Predictive Model for Early Therapeutic Efficacy of Colorectal Liver Metastases Using Multimodal MRI Data.

104P the Value of Functional MR-imaging Signature Model for Early Prediction of Chemotherapy Response and Its Guidance for Regimen Adjustment to Improve Efficacy

Research on the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer using SELDI-TOF-MS

Using texture analysis in the development of a potential radiomic signature for early identification of hepatic metastasis in colorectal cancer

Whole Liver Ct Texture Analysis to Predict the Development of Colorectal Liver Metastases-A Multicentre Study

Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis

Texture Analysis on Gadoxetic Acid Enhanced-Mri for Predicting Ki-67 Status in Hepatocellular Carcinoma: A Prospective Study

Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

Value of Texture Analysis Based on Enhanced MRI for Predicting an Early Therapeutic Response to Transcatheter Arterial Chemoembolisation Combined with High-Intensity Focused Ultrasound Treatment in Hepatocellular Carcinoma

Texture Analysis as Imaging Biomarker for recurrence in advanced cervical cancer treated with CCRT

Study on the Changes of CT Texture Parameters Before and after HCC Treatment in the Efficacy Evaluation and Survival Predication of Patients with HCC.

Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study

Magnetic Resonance Texture Analysis for the Identification of Cytokeratin 19-Positive Hepatocellular Carcinoma.

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis